NASDAQ: ARTL
Artelo Biosciences Inc Stock Ownership - Who owns Artelo Biosciences?

Insider buying vs selling

Have Artelo Biosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARTL insiders and whales buy or sell their stock.

ARTL Shareholders

What type of owners hold Artelo Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter Michael Obrien26.11%345,000$3.19MInsider
Gregory D. Gorgas20.66%273,076$2.53MInsider
John Joseph Crawford7.24%95,671$884.96kInsider
Sharon M. Oster4.72%62,373$576.95kInsider
Connie Matsui4.29%56,667$524.17kInsider
Geode Capital Management LLC1.21%16,032$148.30kInstitution
Geneve Corp0.08%1,013$9.37kInsider
Tower Research Capital LLC Trc0.03%447$4.13kInstitution
Ubs Group Ag0.01%89$823.25Institution
Citigroup Inc0.00%9$83.25Institution

1 of 3

ARTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTL1.26%63.09%
BIVI2.25%97.75%
PHIO0.16%99.84%Net BuyingNet Buying
LPTX28.54%71.46%Net Selling
LYRA4.59%95.41%Net SellingNet Selling

Artelo Biosciences Stock Ownership FAQ

Who owns Artelo Biosciences?

Artelo Biosciences (NASDAQ: ARTL) is owned by 1.26% institutional shareholders, 63.09% Artelo Biosciences insiders, and 35.65% retail investors. Peter Michael Obrien is the largest individual Artelo Biosciences shareholder, owning 345,000.00 shares representing 26.11% of the company. Peter Michael Obrien's Artelo Biosciences shares are currently valued at $3.12M.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.